AI In Pharmacovigilance Course: Comprehensive Introduction To The Transformative Impact Of Artificial Intelligence On Drug Safety And Monitoring (ONLINE EVENT: May 18, 2026)

(MENAFN- GlobeNewsWire - Nasdaq) The main market opportunities include leveraging AI for enhanced drug safety, improving adverse event reporting, optimizing signal detection, and advancing risk management in pharmacovigilance, alongside adapting to current regulatory changes.

Dublin, April 14, 2026 (GLOBE NEWSWIRE) -- The "AI in Pharmacovigilance (May 18, 2026)" training has been added to ResearchAndMarkets's offering.
This course will provide a comprehensive introduction to the transformative impact of artificial intelligence on drug safety and monitoring.

This course covers the fundamentals of AI technology, its applications in pharmacovigilance and practical insights into leveraging AI tools for efficient adverse event reporting, signal detection and risk management. Through a mix of theoretical knowledge and practical examples, participants will gain the understanding of available AI solutions in pharmacovigilance practices as well as current regulatory advances.

Who Should Attend:
Who should attend?

• Pharmacovigilance specialists
• Drug safety officers
• Regulatory affairs professionals
• Clinical research associates
• Medical affairs personnel
• Data scientists working in healthcare and pharmaceuticals

Key Topics Covered:

• Introduction to the basics of AI
• AI for adverse event detection and reporting
• AI in drug discovery and drug repurposing
• Ethical considerations and Regulatory landscape
• Future trends and innovations

CPD Hours: 3

Speakers

Graeme Ladds

Graeme Ladds, Director of PharSafer, has over 30 years' experience in the pharmaceutical industry. He began his career in 1989 at Ashbourne Pharmaceuticals as Head of Drug Safety & Medical Information, before going on to become Head of Global Pharmacovigilance at Shire Pharmaceuticals.

He later founded his consultancy and specialist CRO, PharSafer Associates Ltd, where he has supported companies in establishing pharmacovigilance systems, conducting audits across Europe and the USA, developing SOPs, acting as a QP, and supporting regulatory inspections.

Since 1994, Graeme has also been involved in the monitoring of medical devices, including drug-device combinations, structural devices and electrical medical devices. His experience spans clinical trials and global device vigilance, alongside pharmacovigilance activities across both clinical development and post-marketing phases.

For more information about this training visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: Laura Wood,Senior Press Manager... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN14042026004107003653ID1110979284